The University of Wisconsin’s research foundation has signed its first licensing agreement with a private company to develop commercial products using embryonic stem cell technology developed at the school.
The Wisconsin Alumni Research Foundation, which holds the patents to human embryonic stem cell discoveries made at UW-Madison, and Chemicon International of Temecula, Calif., announced the agreement this week.